Arrhythmia Alliance News & Events
November Medical e-News 2018
Here you can get all this month's updates in one simple click.
November e-News 2018
Get all the latest from us this month and find out more about Global AF Aware Week!
October medical e-News 2018
Here is your latest edition of the monthly e-news.
The World Stroke Congress 2018 is hosting a symposium with a panel of experts to discuss Atrial Fibrillation and various ways to advance policies and advocacy initiatives that can help reduce the risk of AF-related stroke.
Our very own Trudie Lobaan will be presenting - Read more to tune in tomorrow at 13:00h EST - 18:00h BST.
October Patient e-News 2018
Get all the latest from us for this month and register for Patients Day 2018!
Making promises for all our hearts
World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease. The annual campaign brings together individuals, families, communities and organisations around the world to participate in activities to take charge of their heart health and that of others. This year’s theme for World Heart Day is to make a promise... for my heart, for your heart, for all our hearts.
We’re supporting the Cardiovascular Health campaign with Media Planet UK
A Mother’s Mission to Educate the World About Arrhythmia
When Trudie Lobban’s daughter Francesca, now 29, was a baby, the girl had fainting episodes up to eight times a day. It took three years until Francesca was diagnosed with Reflex Anoxic Seizures (RAS), a condition that caused her heart to briefly stop.
Arrhythmia Alliance Educates Individuals on the Risks of Heart Rhythm Disorders for World Heart Day 2018
September 20, 2018: World Heart Day is a global campaign to raise awareness of heart health and Arrhythmia Alliance is urging everyone to Know Your Pulse to know your heart rhythm.
Should We Switch Patients Who Appear to Be Optimally Anticoagulated on Warfarin to DOACs?*
wo different types of oral anticoagulants (OACs) are currently available to reduce the risk of stroke/systemic embolism (SE) in patients with atrial fibrillation (AF): vitamin K antagonists (VKAs) and direct OACs (DOACs) (1).